van Gemert Martin J C, Nikkels Peter G J, Paarlberg K Marieke, van den Wijngaard Jeroen P H M, Gardiner Helena M
Department of Biomedical Engineering & Physics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pathology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands.
Birth Defects Res A Clin Mol Teratol. 2016 Sep;106(9):733-8. doi: 10.1002/bdra.23531. Epub 2016 Jun 7.
We recently published pump/acardiac umbilical venous diameter (UVD) ratios, representing the pump twin's excess cardiac output fraction, of 27 acardiac twin pregnancies. There was a clear separation between the 17 pump twins that had life-threatening complications and the 10 that did not. The hypothesis of this study is that placental chorangioma and sacrococcygeal teratoma (SCT), tumors whose perfusion also causes high-output complications, have the same fetal outcome as pump twins when perfusion of the tumor requires the same excess cardiac output fraction.
We compared the three fetoplacental circulations. Fetuses with a placental chorangioma and acardiac twin pregnancies both have their feeding artery and draining vein located at the placental cord insertion. In contrast, SCT lacks a prescribed feeding artery and draining vein. We, therefore, had to modify our model to assume that the diameter of the hypothetical draining vein is related to the flow difference between inferior vena cava and superior vena cava. The latter flow has been estimated sonographically and is the same as the inferior vena cava flow in the absence of an SCT. Furthermore, a simple modification accounts for the different location of the tumor with respect to the placental cord insertion.
We propose to apply the clinical pump/acardiac UVD ratios to pregnancies complicated by placental chorangiomas and the modified pump/acardiac UVD ratios for SCT.
Risk prediction of these rare fetal tumors may be possible based on application of data on excess cardiac output fractions from pump/acardiac UVD ratios and will require future clinical validation. Birth Defects Research (Part A) 106:733-738, 2016. © 2016 Wiley Periodicals, Inc.
我们最近公布了27例无心双胎妊娠中泵血儿/无心儿脐静脉直径(UVD)比值,该比值代表泵血儿额外的心输出量分数。在17例出现危及生命并发症的泵血儿与10例未出现此类并发症的泵血儿之间存在明显差异。本研究的假设是,胎盘绒毛膜血管瘤和骶尾部畸胎瘤(SCT),其灌注也会导致高输出量并发症,当肿瘤灌注需要相同的额外心输出量分数时,其胎儿结局与泵血儿相同。
我们比较了三种胎儿 - 胎盘循环。患有胎盘绒毛膜血管瘤的胎儿和无心双胎妊娠的胎儿,其供血动脉和引流静脉均位于胎盘脐带附着处。相比之下,SCT没有特定的供血动脉和引流静脉。因此,我们不得不修改我们的模型,假设假想引流静脉的直径与下腔静脉和上腔静脉之间的血流差异有关。后者的血流已通过超声估计,并且在没有SCT的情况下与下腔静脉血流相同。此外,一个简单的修改考虑了肿瘤相对于胎盘脐带附着处的不同位置。
我们建议将临床泵血儿/无心儿UVD比值应用于合并胎盘绒毛膜血管瘤的妊娠,并将修改后的泵血儿/无心儿UVD比值应用于SCT。
基于泵血儿/无心儿UVD比值中额外心输出量分数的数据应用,对这些罕见胎儿肿瘤进行风险预测可能是可行的,并且需要未来的临床验证。《出生缺陷研究(A部分)》106:733 - 738,2016年。©2016威利期刊公司。